Publication:
70 Years of Levothyroxine

datacite.subject.fos oecd::Medical and Health sciences
dc.contributor.author George J. Kahaly (Editors)
dc.date.accessioned 2023-06-19T01:34:24Z
dc.date.available 2023-06-19T01:34:24Z
dc.date.issued 2021
dc.description DOI: https://doi.org/10.1007/978-3-030-63277-9 License: CC BY; Publisher: Springer
dc.description.abstract "This open access book presents the history, pharmacokinetics and pharmacodynamics of levothyroxine, discussing its role in the thyroid pathophysiology of patients of various ages and during pregnancy. It also describes the influence of levothyroxine on heart, bone and in cancer. When it was first synthesized in 1949, levothyroxine represented a significant advance in the treatment of hypothyroidism, providing a safe and effective treatment option for millions of hypothyroid patients around the globe. This synthetic form of thyroxine is now one of the most prescribed drugs in the world. Levothyroxine was first introduced by Merck KGaA,Darmstadt, Germany, in 1972, and since then the company has remained actively engaged in research on this mainstay of hypothyroidism treatment. This book is intended for healthcare professionals." This work is licensed under a CC BY
dc.identifier.doi https://doi.org/10.1007/978-3-030-63277-9
dc.identifier.isbn 9783030632779
dc.identifier.uri http://repository.vlu.edu.vn:443/handle/123456789/5604
dc.language.iso en
dc.subject "Thyroid gland
dc.subject Hypothyroidism
dc.subject TSH
dc.subject Thyroid disorders
dc.subject Metabolism
dc.subject Endocrinology
dc.subject Open Access"
dc.title 70 Years of Levothyroxine
dc.type Resource Types::text::book
dspace.entity.type Publication
oairecerif.author.affiliation #PLACEHOLDER_PARENT_METADATA_VALUE#
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
OAB623_70 Years of Levothyroxine.txt
Size:
13 B
Format:
Plain Text
Description: